πŸ‡ΊπŸ‡Έ FDA
Patent

US 10363293

Vaccine composition

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 10363293 (Vaccine composition) held by TURNSTONE LIMITED PARTNERSHIP expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNSTONE LIMITED PARTNERSHIP
Grant date
Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/545, A61K2039/55561